Takara Bio Revenue

In the fiscal year ending March 31, 2025, Takara Bio had annual revenue of 45.04B JPY with 3.53% growth. Takara Bio had revenue of 15.76B in the quarter ending March 31, 2025, with 14.42% growth.

Revenue

45.04B

Revenue Growth

+3.53%

P/S Ratio

2.05

Revenue / Employee

24.50M

Employees

1,838

Market Cap

92.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	45.04B	1.53B	3.53%
Mar 31, 2024	43.51B	-34.64B	-44.33%
Mar 31, 2023	78.14B	10.44B	15.43%
Mar 31, 2022	67.70B	21.61B	46.90%
Mar 31, 2021	46.09B	11.52B	33.33%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Daiichi Sankyo Company	1,886.26B
Takeda Pharmaceutical Company	4,581.55B
HOYA Corporation	869.37B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Olympus	997.33B

Revenue Rankings